Xiao Jiansheng, Chen Hua, Ge Jiaqi, Kuang Jin, Huang Xin, Zhai Qiliang, Fan Difu, Song Leming, Liu Tairong
Department of Urology, Jiangxi Medical College, Ganzhou People's Hospital, Nanchang University, No. 16 Meiguan Avenue, Zhanggong District, Ganzhou, Jiangxi, China.
World J Urol. 2025 Jun 20;43(1):381. doi: 10.1007/s00345-025-05776-1.
This study aimed to evaluate the safety and efficacy of flexible vacuum-assisted ureteral access sheath (FV-UAS) and intelligent pressure-controlled ureteral access sheath (IPC-UAS) in retrograde intrarenal surgery (RIRS) for the treatment of 2-4 cm renal stones.
We retrospectively analyzed clinical data from patients who underwent RIRS at the Department of Urology, Ganzhou People's Hospital, between October 2022 and December 2024. Patients were divided into two groups based on the type of ureteral access sheath used during surgery. Clinical outcomes were compared between groups, including stone-free rate (SFR) on postoperative day 1 and month 1 follow-up, complication rate, operative time, average length of hospital stay, and postoperative pain scores.
The FV-UAS group achieved significantly higher SFR compared to the IPC-UAS group, with rates of 84.02% on postoperative day 1 and 88.66% at month 1, versus 74.87% and 80.21%, respectively(P < 0.05). However, the FV-UAS group also exhibited a higher complication rate (15.98%) than the IPC-UAS group (9.44%) (P = 0.043). In cases involving lower pole stones, the use of a stone retrieval basket was notably lower in the FV-UAS group (1.34%) compared to the IPC-UAS group (5.34%) (P = 0.042). No statistically significant differences were observed between the groups in terms of stone composition, operative time, hospital stay duration, or intraoperative hemoglobin loss (P > 0.05).
Both FV-UAS and IPC-UAS are effective and safe for managing large renal stones in RIRS. FV-UAS can achieve a higher SFR, while IPC-UAS demonstrates a lower rate of complications.
本研究旨在评估柔性真空辅助输尿管通路鞘(FV-UAS)和智能压力控制输尿管通路鞘(IPC-UAS)在逆行肾内手术(RIRS)治疗2-4厘米肾结石中的安全性和有效性。
我们回顾性分析了2022年10月至2024年12月在赣州市人民医院泌尿外科接受RIRS治疗的患者的临床资料。根据手术中使用的输尿管通路鞘类型将患者分为两组。比较两组的临床结果,包括术后第1天和术后1个月随访时的无石率(SFR)、并发症发生率、手术时间、平均住院时间和术后疼痛评分。
FV-UAS组的SFR显著高于IPC-UAS组,术后第1天的SFR为84.02%,术后1个月为88.66%,而IPC-UAS组分别为74.87%和80.21%(P<0.05)。然而,FV-UAS组的并发症发生率(15.98%)也高于IPC-UAS组(9.44%)(P=0.043)。在涉及下极结石的病例中,FV-UAS组使用结石取出篮的比例(1.34%)明显低于IPC-UAS组(5.34%)(P=0.042)。两组在结石成分、手术时间、住院时间或术中血红蛋白丢失方面均未观察到统计学显著差异(P>0.05)。
FV-UAS和IPC-UAS在RIRS治疗大型肾结石方面均有效且安全。FV-UAS可实现更高的SFR,而IPC-UAS的并发症发生率较低。